CSP
ABBV icon

Cary Street Partners’s AbbVie ABBV Stock Holding History

Cary Street Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.4M Buy
132,877
+3,964
+3% +$853K 0.73% 26
2026
Q1 		$28M Sell
128,913
-872
-0.7% -$193K 0.69% 31
2025
Q4 		$29.7M Sell
129,785
-2,033
-2% -$463K 0.73% 27
2025
Q3 		$30.5M Buy
131,818
+1,633
+1% +$333K 0.79% 26
2025
Q2 		$24.2M Buy
130,185
+779
+0.6% +$145K 0.68% 29
2025
Q1 		$27.1M Buy
129,406
+6,393
+5% +$1.24M 0.86% 20
2024
Q4 		$21.9M Buy
+123,013
New +$22.6M 0.71% 27

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Cary Street Partners's ABBV Position: Q2 2026 in Review

Cary Street Partners increased its AbbVie (ABBV) stake by 3.1% in Q2 2026, buying an estimated $853K and bringing the position to 132,877 shares worth $33.4M. The position accounts for 0.73% of the portfolio, ranked #26.

Cary Street Partners first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cary Street Partners held 132,877 shares of AbbVie worth $33.4M as of Q2 2026.
  • Cary Street Partners bought 3,964 AbbVie shares in Q2 2026, an estimated $853K.
  • AbbVie made up 0.73% of Cary Street Partners's portfolio in Q2 2026, its #26 holding.
  • Cary Street Partners first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.